Published in Med Gas Res on April 16, 2015
The Response of Macrophages and Neutrophils to Hypoxia in the Context of Cancer and Other Inflammatory Diseases. Mediators Inflamm (2016) 0.77
New Beginnings for Medical Gas Research. Med Gas Res (2016) 0.75
Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injury. Med Gas Res (2016) 0.75
What's new in Medical Gas Research: Highlights for 2015. Med Gas Res (2016) 0.75
Molecular hydrogen: a therapeutic antioxidant and beyond. Med Gas Res (2016) 0.75
For the pursuit of oxygen and carbon dioxide channels in mitochondria. Med Gas Res (2016) 0.75
Inflammatory bowel disease. N Engl J Med (2002) 21.17
Hypoxia and inflammation. N Engl J Med (2011) 7.71
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology (1984) 6.17
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature (2013) 5.44
HIF-1 and human disease: one highly involved factor. Genes Dev (2000) 5.41
Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev (2005) 4.08
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest (2004) 3.90
The role of nitric oxide in tumour progression. Nat Rev Cancer (2006) 3.08
A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A (2005) 2.53
A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med (2002) 2.34
Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol (2001) 2.13
Hypoxia and gastrointestinal disease. J Mol Med (Berl) (2007) 2.06
Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med (2002) 1.93
Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A (2012) 1.70
Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology (2008) 1.57
Management of acute severe ulcerative colitis. Gut (2010) 1.53
Inflammatory hypoxia: role of hypoxia-inducible factor. Cell Cycle (2005) 1.50
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol (2003) 1.47
Recent advances in IBD pathogenesis: genetics and immunobiology. Curr Gastroenterol Rep (2008) 1.23
Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system. Dig Dis Sci (2001) 1.21
Visceral surface oxygen tension in experimental colitis in the rabbit. J Lab Clin Med (1988) 1.06
Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats. Eur J Gastroenterol Hepatol (2000) 1.05
A hypothesis on the pathogenesis of rheumatoid and other non-specific synovitides. IV A. The possible intermediate role of local hypoxia and metabolic alterations. Med Hypotheses (1984) 0.98
Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut (1998) 0.98
Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol (1997) 0.96
Effect of hypoxic hypoxia on transmural gut and subcutaneous tissue oxygen tension. Adv Exp Med Biol (1997) 0.89
Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol (1994) 0.87
Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res (2004) 0.86
Hyperbaric oxygenation in severe perineal Crohn's disease. Dis Colon Rectum (1995) 0.85
Inverse correlation between metallothioneins and hypoxia-inducible factor 1 alpha in colonocytes and experimental colitis. Biochem Biophys Res Commun (2011) 0.84
TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. Mol Cell Biochem (2009) 0.84
HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis. J Leukoc Biol (2012) 0.84
Down-regulation of hypoxia-inducible factor-1alpha by hyperbaric oxygen attenuates the severity of acute pancreatitis in rats. Pancreas (2009) 0.84
The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis. Dig Dis Sci (2008) 0.83
Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis. Scand J Gastroenterol (2003) 0.82
Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis. Dig Dis Sci (2007) 0.81
Hyperbaric oxygen improves healing in experimental rat colitis. Undersea Hyperb Med (2002) 0.80
Expression of checkpoint kinase 2 in breast carcinomas: correlation with key regulators of tumor cell proliferation, angiogenesis, and survival. Histol Histopathol (2006) 0.80
A different therapeutic approach in patients with severe ulcerative colitis: hyperbaric oxygen treatment. South Med J (2003) 0.79
Crohn's disease and hyperbaric oxygen therapy. Acta Cir Bras (2011) 0.78